Safe, Flexible & Proven- Gen 2.0 Basal Insulin Therapy for consistent and predictable outcomes
Featuring a podcast with Dr. Steven Edelman, where he reviews the evidence behind a second-generation basal insulin like Gla-300 and its ability to provide consistent and predictable basal insulin coverage with once-daily administration, supporting simplified and individualized diabetes management.
Safe, Flexible & Proven- Gen 2.0 Basal Insulin Therapy to match daily life needs of people with T2DM
Here's a podcast starring Pr. Stewart Harris and Pr. Othmar Moser, discussing the importance of simple dosing and titration, flexible to match daily life needs
Safe, Flexible and Proven: Gen 2.0 Basal Insulin Therapy Across Diverse T2D Populations
Join Dr. Alice Cheng as she reviews the evidence behind second-generation basal insulins and their role in delivering safe, flexible, and proven glycemic control across diverse Type 2 diabetes populations, including older adults and those with renal impairment.
Soli-SWITCH study
Efficacy and safety of switching to iGlarLixi from premixed insulins in people with type 2 diabetes
Patient-Information-Sketch
Toujeo-interactive-popup-1
Toujeo-interactive-popup-2
Toujeo-interactive-popup-3
A-single-dose-of-Glulisine-Glargine-video
Basal-plus-regime-Simple-Effective-Low-risk-of-hypoglycemia
